Journal Report

CLINICAL CANCER RESEARCH

Download PDF
Journal Information
Journal Title
CLINICAL CANCER RESEARCH
Publisher
AMER ASSOC CANCER RESEARCH
ISSN
1078-0432
E-ISSN
1557-3265
Database
Clarivate
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Kinetics of Re-differentiation with Short-Course Dabrafenib and Trametinib in Patients with Radioiodine-Refractory Thyroid Cancer
Samantha Peiling. Yang, Kelvin Siu Hoong. Loke, Wei Ming Chua et al.
2026-11-9
DOI: 10.1158/1078-0432.ccr-26-2415
BRCA1 at the Crossroads of Genome Stability, Mitochondrial Homeostasis, and Tumor Immunity
Zahra Gohari, Lora Stojanovic, Kenneth P. Nephew et al.
2026-11-9
DOI: 10.1158/1078-0432.ccr-26-2385
Efficacy and Safety of Alectinib in Pediatric and Adult Patients with <i>ALK</i> -Altered Advanced Solid Tumors: A Phase II TACKLE Trial (NCCH1712/MK003)
Hitomi S. Okuma, Ayumu Arakawa, Akihiro Hirakawa et al.
2026-11-6 Pages OF1-OF9
DOI: 10.1158/1078-0432.ccr-26-1548
Phase I Trial and Biomarker Analysis of Buparlisib with Weekly Cisplatin and Radiotherapy in High-risk Locally Advanced Squamous Cell Cancer of the Head and Neck
Jochen H. Lorch, Kristine Wong, Roy B. Tishler et al.
2026-11-6 Pages OF1-OF9
DOI: 10.1158/1078-0432.ccr-21-3677
Comparison of PSMA- and CD70-targeted PET/CT in The Diagnosis of Renal Cell Carcinoma: A Retrospective Cohort and Prospective Head-to-head Study
Herui Li, Qiufang Liu, Xuebing Yu et al.
2026-11-6
DOI: 10.1158/1078-0432.ccr-26-2321
Impact of Dosage Modifications on Efficacy: Insights from Select Tyrosine Kinase Inhibitors Approved for Treatment of Non-Small Cell Lung Cancer with EGFR Mutations
Santiago D. Carrasquilla, Youwei Bi, Wenjuan Gu et al.
2026-11-6
DOI: 10.1158/1078-0432.ccr-26-1022
Multiomics Analysis of Malignant Pleural Mesothelioma Reveals the Immunological Microenvironment Associated with <i>MTAP</i> Loss and Immunotherapy Outcomes
Akiko Tateishi, Tatsuya Yoshida, Kouya Shiraishi et al.
2026-11-6
DOI: 10.1158/1078-0432.ccr-26-1855
DNA-Based Biomarkers as Predictors of Carboplatin Response in Neoadjuvant Treatment for Hormone Receptor-Positive and Triple-Negative Breast Cancer
Arne V. Pladsen, Marianne L. Smebye, Øystein Garred et al.
2026-11-6 Pages OF1-OF10
DOI: 10.1158/1078-0432.ccr-26-2212
Integrated multi-omics reveals longitudinal metabolic dynamics and reprogramming in bladder cancer
Yadi Zhong, Yuqing Li, Qian Wang et al.
2026-11-6
DOI: 10.1158/1078-0432.ccr-26-1201
Differential Impact of Tumor-Derived <i>ESR1</i> Mutations on Elacestrant Benefit in Metastatic Breast Cancer
George W. Sledge, Joanne Xiu, Suzanne Fuqua et al.
2026-11-4 Pages OF1-OF10
DOI: 10.1158/1078-0432.ccr-26-2215
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 9, 2026 23:31